Please login to the form below

Not currently logged in
Email:
Password:

PureTech appoints new chief financial officer

Former Biogen VP Michael Maclean joins company

Boston-based PureTech Health has appointed Michael Maclean as its chief financial officer.

Maclean joins from Fortune 1000 firm Iron Mountain where he served as chief financial officer of the North American business.

He said: “In my various roles, I've looked closely at many businesses in the healthcare sector and PureTech stands out as truly innovative.

“I look forward to joining the stellar PureTech team and contributing during this exciting phase of growth for the company.”

Previously Maclean was senior VP of finance at Biogen, during which he oversaw finance and accounting and was responsible for managing strategic collaborations and acquisitions. He has also supported global clients in the pharmaceutical, medical device and diagnostics sectors while working as audit partner at KPMG.

Daphne Zohar, co-founder and CEO of PureTech, said: “His wealth of experience in finance and accounting across multiple disciplines, including deal structuring and acquisitions in the healthcare sector, will be a great addition to PureTech as our growth stage companies move towards commercialisation.”

15th September 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...